Skip to Main Content

Author Details

Catharina Scholl
Federal Institute for Drugs and Medical Devices (BfArM)
2008
37
13
Kirsten Obernier (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36484792Inhalation therapies in COPD - adverse drug reactions impact on emergency department presentations.Eur J Clin Pharmacol2023
37787843Current status of the analytical validation of next generation sequencing applications for pharmacogenetic profiling.Mol Biol Rep2023
37767130Whole genome transcriptome data from the WT cortex and hippocampus of female and male control and APP/PS1 Alzheimer's disease mice.Data Brief2023
37382655Use of overactive bladder anticholinergic medications associated with falls leading to emergency department visits: results from the ADRED study.Eur J Clin Pharmacol2023
34905151Molecular Genetic Techniques in Biomarker Analysis Relevant for Drugs Centrally Approved in Europe.Mol Diagn Ther2022
35102241Evaluation of the EMPAR study population on the basis of metabolic phenotypes of selected pharmacogenes.Pharmacogenomics J2022
35190514Population genetic polymorphisms of pharmacogenes in Zimbabwe, a potential guide for the safe and efficacious use of medicines in people of African ancestry.Pharmacogenet Genomics2022
35213393Green Tea Extract to Prevent Colorectal Adenomas, Results of a Randomized, Placebo-Controlled Clinical Trial.Am J Gastroenterol2022
34935441Catch Me if You Can: the Crosstalk of Zika Virus and the Restriction Factor Tetherin.J Virol2022
34025403CYP2D6 in the Brain: Potential Impact on Adverse Drug Reactions in the Central Nervous System-Results From the ADRED Study.Front Pharmacol2021
33601063Targeting Cholesterol Metabolism as Efficient Antiviral Strategy Against the Hepatitis E Virus.Cell Mol Gastroenterol Hepatol2021
34497262Genetic polymorphism of CYP2C19 and subcortical variability in the human adult brain.Transl Psychiatry2021
34681280Individualized versus Standardized Risk Assessment in Patients at High Risk for Adverse Drug Reactions (The IDrug Randomized Controlled Trial)-Never Change a Running System?Pharmaceuticals (Basel)2021
34012511Association between miRNA signatures in serum samples from epidermal growth factor inhibitor treated patients and skin toxicity.Oncotarget2021
34206978Cytogenetic and Biochemical Genetic Techniques for Personalized Drug Therapy in Europe.Diagnostics (Basel)2021
32527038Adverse Drug Reactions in the Emergency Department: Is There a Role for Pharmacogenomic Profiles at Risk?-Results from the ADRED Study.J Clin Med2020
33121145Impact of Zika Virus Infection on Human Neural Stem Cell MicroRNA Signatures.Viruses2020
33024081Effects of genetic variability of CYP2D6 on neural substrates of sustained attention during on-task activity.Transl Psychiatry2020
32612257Citalopram-induced pathways regulation and tentative treatment-outcome-predicting biomarkers in lymphoblastoid cell lines from depression patients.Transl Psychiatry2020
29735005Adverse Drug Reactions (ADR) and Emergencies.Dtsch Arztebl Int2018
29466429Population nutrikinetics of green tea extract.PLoS One2018
28291260Gene expression and proliferation biomarkers for antidepressant treatment resistance.Transl Psychiatry2017
28456787Predictive blood plasma biomarkers for EGFR inhibitor-induced skin rash.Oncotarget2017
26820683Dosing to rash?--The role of erlotinib metabolic ratio from patient serum in the search of predictive biomarkers for EGFR inhibitor-mediated skin rash.Eur J Cancer2016
27845776Proliferation rates and gene expression profiles in human lymphoblastoid cell lines from patients with depression characterized in response to antidepressant drug therapy.Transl Psychiatry2016
26830424[Personalized drug therapy based on genetics. Possibilities and examples from clinical practice].Internist (Berl)2016
25943212CHL1, ITGB3 and SLC6A4 gene expression and antidepressant drug response: results from the Munich Antidepressant Response Signature (MARS) study.Pharmacogenomics2015
26419366High-throughput screening identified inherited genetic variations in the EGFR pathway contributing to skin toxicity of EGFR inhibitors.Pharmacogenomics2015
26521924Gene regulatory biomarker identification for skin toxicities induced by EGFR inhibitor treatment.Int J Clin Pharmacol Ther2015
24448162Proliferation and cilia dynamics in neural stem cells prospectively isolated from the SEZ.Sci Rep2014
24857781Cytokine regulation by epidermal growth factor receptor inhibitors and epidermal growth factor receptor inhibitor associated skin toxicity in cancer patients.Eur J Cancer2014
24147127Zonation of nitrogen and glucose metabolism gene expression upon acute liver damage in mouse.PLoS One2013
22458731A fast and efficient polymerase chain reaction-based method for the preparation of in situ hybridization probes.Histopathology2012
23177197Indirubin derivatives modulate TGFβ/BMP signaling at different levels and trigger ubiquitin-mediated depletion of nonactivated R-Smads.Chem Biol2012
22748179Distinct and overlapping gene regulatory networks in BMP- and HDAC-controlled cell fate determination in the embryonic forebrain.BMC Genomics2012
21603599Real-time monitoring of cisplatin-induced cell death.PLoS One2011
18546086TCF7L2 polymorphism rs7903146 and predisposition for type 2 diabetes mellitus in obese children.Horm Metab Res2008
  • 1 - 37 of 37

Recommended Authors

Lang Li
College of Medicine, The Ohio State University
Career Start Year 2018
Number of shared co-authors 0
Li Gong
Stanford University
Career Start Year 2004
Number of shared co-authors 1
James K Hicks
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2004
Number of shared co-authors 1
Rubin Lubomirov
Clinical Development
Career Start Year 2003
Number of shared co-authors 1
Lang Li
Harbin Medical University
Career Start Year 2002
Number of shared co-authors 0
Alison A Motsinger-Reif
National Institute of Environmental Health Sciences
Career Start Year 2002
Number of shared co-authors 1
Albert Rosenberger
University of Goettingen
Career Start Year 2001
Number of shared co-authors 1
Sook Wah Yee
University of California San Francisco
Career Start Year 2001
Number of shared co-authors 1
Eric W Klee
Mayo Clinic College of Medicine and Science
Career Start Year 2001
Number of shared co-authors 0
Gregory D Jenkins
Mayo Clinic
Career Start Year 2001
Number of shared co-authors 1
Stefan Herms
Institute of Human Genetics, University of Bonn
Career Start Year 2001
Number of shared co-authors 7
Cristina Rodr??guez-Antona
Spanish National Cancer Research Center (CNIO)
Career Start Year 2000
Number of shared co-authors 0
Stuart A Scott
Stanford University
Career Start Year 2000
Number of shared co-authors 1
Liewei Wang
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 0
Kerby Shedden
University of Michigan ann arbor
Career Start Year 1999
Number of shared co-authors 0
Lara M Mangravite
Children's Hospital Oakland Research Institute
Career Start Year 1998
Number of shared co-authors 0
Taimour Y Langaee
Center for Pharmacogenomics and Precision Medicine, University of Florida
Career Start Year 1998
Number of shared co-authors 0
Patricia Porter-Gill
Arkansas Children's Research Institute
Career Start Year 1998
Number of shared co-authors 0
Michael R Barnes
William Harvey Research Institute, Queen Mary University of London
Career Start Year 1997
Number of shared co-authors 2
Michelle Whirl-Carrillo
Stanford University
Career Start Year 1995
Number of shared co-authors 1
Sudhir Varma
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 0
Deanna L Kroetz
University of California San Francisco
Career Start Year 1993
Number of shared co-authors 0
Weida Tong
National Center for Toxicological Research
Career Start Year 1992
Number of shared co-authors 0
Bruce C Carleton
BC Children's Hospital Research Institute
Career Start Year 1991
Number of shared co-authors 0
Russell A Wilke
University of South Dakota Sanford School of Medicine
Career Start Year 1989
Number of shared co-authors 0
Jacques Demotes-Mainard
The European Clinical Research Infrastructure Network (ECRIN)
Career Start Year 1986
Number of shared co-authors 0
Teri E Klein
Stanford University
Career Start Year 1986
Number of shared co-authors 1
Vidar M Steen
University of Oslo, Oslo University Hospital
Career Start Year 1984
Number of shared co-authors 4
Howard L McLeod
Center for Precision Medicine and Functional Genomics, Utah Tech University
Career Start Year 1979
Number of shared co-authors 1
Giovanni Severino
University of Cagliari.
Career Start Year 1979
Number of shared co-authors 2

Collaborators

Michael Steffens
Federal Institute for Drugs and Medical Devices (BfArM)
Co-authored papers 16
Stefan W??lfl
Institute of Pharmacy and Molecular Biotechnology, Heidelberg University
Co-authored papers 6
Matthias Schwab
and of Biochemistry and Pharmacy, University of Tuebingen
Co-authored papers 4
Agapios Sachinidis
Institute of Neurophysiology, University of Cologne
Co-authored papers 2
Gonzalo Laje
Gothenburg University.
Co-authored papers 2
Johannes Winkler
Medical University of Vienna
Co-authored papers 1
Markus M N??then
Institute of Human Genetics, University Hospital Bonn
Co-authored papers 1
Gabriele H??lzl-Wenig
Universitat Heidelberg
Co-authored papers 1
Thuy Trang Nguyen
Co-authored papers 1
Priti Khatri
Interdisciplinary Center for Neurosciences (IZN), University of Heidelberg
Co-authored papers 1
Anke Hinney
University Hospital Essen, University of Duisburg-Essen
Co-authored papers 1
Kirsten Obernier (CM4AI)
University of California San Francisco
Co-authored papers 1
John Antonydas Gaspar
Research Centre, Ananda College
Co-authored papers 1
Ina K Simeonova
Interdisciplinary Center for Neurosciences (IZN), University of Heidelberg
Co-authored papers 1
Francesca Ciccolini
Universitat Heidelberg
Co-authored papers 1
J??rgen Hescheler
Institute of Neurophysiology, University of Cologne
Co-authored papers 1
Andrea Hellwig
Interdisciplinary Center for Neurosciences (IZN), University of Heidelberg
Co-authored papers 1
Johannes Hebebrand
LVR-Universitatsklinikum Essen, Kliniken und Institut der Universitat Duisburg-Essen
Co-authored papers 1
Claudia Mandl
Interdisciplinary Center for Neurosciences (IZN), University of Heidelberg
Co-authored papers 1
Andreas Till
University Hospital Bonn
Co-authored papers 1
Release 1.2